Insmed (INSM) Short-term Investments (2010 - 2026)

Insmed's Short-term Investments history runs 9 years deep, the most recent figure standing at $641.3 million for Q1 2026.

• In Q1 2026, Short-term Investments fell 19.45% year-over-year to $641.3 million; the TTM figure through Mar 2026 stood at $641.3 million (down 19.45% YoY), while the FY2025 annual figure was $919.6 million, up 4.64% from the prior year.
• Short-term Investments was $641.3 million for Q1 2026 at Insmed, down from $919.6 million in the prior quarter.
• In the past five years, Short-term Investments ranged from a high of $1.3 billion in Q3 2025 to a low of $29.8 million in Q1 2023.
• Historically, Short-term Investments has averaged $501.5 million across 5 years, with a median of $304.9 million in 2023.
• Biggest YoY gain for Short-term Investments was 301.48% in 2023; the steepest drop was 75.07% in 2023.
• A 5-year view of Short-term Investments shows it stood at $74.2 million in 2022, then jumped by 301.48% to $298.1 million in 2023, then soared by 194.83% to $878.8 million in 2024, then increased by 4.64% to $919.6 million in 2025, then plunged by 30.26% to $641.3 million in 2026.
• The last three Short-term Investments figures came in at $641.3 million (Q1 2026), $919.6 million (Q4 2025), and $1.3 billion (Q3 2025), per Business Quant data.